Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of Capecitabine With Weekly Paclitaxel for Advanced Breast Cancer

NCT00031876 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT00031876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00031876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of Capecitabine With Weekly Paclitaxel for Advanced Breast Cancer
Lead sponsor
Swiss Cancer Institute
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2000
Completion date
September 30, 2004
Enrollment
34 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer